Market News
Global Nicotine Replacement Therapy Market- Recent Developments
Product and technology Launch
- In September 2022, 22nd Century Group, a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, launched VLN, a low-nicotine cigarette in Colorado, U.S.
- In May 2022, Innokin Technology, a leading vape brand & manufacturer, launched a lineup of vaporizers with water-based vaping technology with water-based juice, AQ30. Water-based vaping delivers smoother vapor and faster satisfaction than traditional vaping systems and reduces the dehydrating qualities of vapor.
- In August 2022, MOK, the leading brand from Shenzhen IVPS Technology, specializing in the research and development, production and sales of e-cigarettes, launched its new SOLUS 2 series at a special global product launch event in Jakarta, Indonesia. SOLUS 2 Series, an upgraded version of the SOLUS series of Vaping Devices.
Business Development Activities by the Market Players
- In November 2022, Philip Morris International Inc., a U.S.-based multinational tobacco company, announced the launch of its latest heat-not-burn tobacco heating system, BONDS by IQOS with its accompanying specially designed tobacco sticks, BLENDS. A new product from IQOS, the world's No. 1 tobacco heating system. BONDS by IQOS offers adults who would otherwise continue to smoke access to a compact, low maintenance and hassle-free to use smoke-free offer—validated by science—as a better alternative to cigarettes—to accelerate the achievement of a smoke-free future.
- In September 2022, Qnovia, Inc. (Qnovia), a pharmaceutical company developing inhaled therapeutics with an initial focus on nicotine replacement therapy (NRT) and cardiopulmonary diseases, announced that it had raised US$ 17 million in Series A funding. The financing was led by Blue Ledge Capital and included DG Ventures, Evolution VC Partners, Gaingels, TL Capital, and Vice Ventures, investment firms.